Amethyst Radiotherapy Group, a Pan European oncology company, secured a €300m financing agreement with Credit funds managed by Ares Management Corporation, a global alternative investment manager.
This investment positions Amethyst as a leading player in the European oncology sector, as it continues to accelerate its expansion. By broadening its footprint, the company aims to bring innovative cancer care to more patients, addressing the escalating demand for accessible and high-quality oncological services.
Led by Stéphane Carré, CEO, Amethyst Radiotherapy is a private operator of radiotherapy, providing state-of-the-art cancer treatment across Europe, in six countries. With a focus on advanced technology and patient-centred care, the company is dedicated to improving health outcomes for cancer patients and to provide an innovative and supportive environment for healthcare professionals.
They operate 15 centres across Austria, France, Italy, Poland, Romania and the UK.
FinSMEs
03/07/2024